Recruiting
Atrial fibrillation
RecruitingStudy on Preventing Blood Clots in Patients with New-Onset Post-Operative Atrial Fibrillation after CABG Using Apixaban and Drug Combination
Registered drugNo placebo
Study on Preventing Blood Clots in Patients with New-Onset Post-Operative Atrial Fibrillation after CABG Using Apixaban and Drug Combination
Registered drugNo placebo
- Disease:Atrial fibrillation
- Substances:Acetylsalicylic AcidApixaban+7
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:Acetylsalicylic Acid
